Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•
Drug & Salt Regulations

ICH Q14 & Q2(R2) Analytical Procedure Development & Validation Standards for Generic Drug Master Files

Regulatory adoption briefing for the revised ICH Q14 (Analytical Procedure Development) and ICH Q2(R2) (Validation of Analytical Procedures) guidelines governing Active Substance Master Files (ASMFs) and US DMFs.

  • Validation Scope: Expanded multivariate analytical design incorporating Analytical Target Profiles (ATP), HPLC/UPLC gradient robustness, and System Suitability Testing (SST) for assay and related substances.
  • Lifecycle Management: Established Conditions (ECs) for analytical procedures allow structured post-approval change management under ICH Q12 frameworks.

Official Source & Verification Reference

Issuing Authority: International Council for Harmonisation (ICH) • Reference: ICH-Q14-Q2R2-STEP5

Verify Official Source Document ↗
ICH Q14 & Q2(R2) Analytical Procedure Development & Validation Standards for Generic Drug Master Files | PharmaTrade Online Market Bulletin | PharmaTrade Online